The role involves leading the early clinical development strategy for novel therapy programs from preclinical candidate approval through Phase 2 proof-of-concept.
Base: $260,300.00 - $409,700.00; Bonus/Equity: Annual bonus and long-term incentive eligible; Benefits: Medical, dental, vision, 401(k), paid holidays, vacation
Must-have
Nice-to-have
Not specified